vs

Side-by-side financial comparison of MERCURY SYSTEMS INC (MRCY) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

MERCURY SYSTEMS INC is the larger business by last-quarter revenue ($235.8M vs $142.0M, roughly 1.7× Oncology Institute, Inc.). MERCURY SYSTEMS INC runs the higher net margin — -1.2% vs -5.3%, a 4.1% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 11.5%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-1.8M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -2.6%).

Mercury Systems, Inc. is a technology company serving the aerospace and defense industry. It designs, develops and manufactures open architecture computer hardware and software products, including secure embedded processing modules and subsystems, avionics mission computers and displays, rugged secure computer servers, and trusted microelectronics components, modules and subsystems.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

MRCY vs TOI — Head-to-Head

Bigger by revenue
MRCY
MRCY
1.7× larger
MRCY
$235.8M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+30.0% gap
TOI
41.6%
11.5%
MRCY
Higher net margin
MRCY
MRCY
4.1% more per $
MRCY
-1.2%
-5.3%
TOI
More free cash flow
TOI
TOI
$4.0M more FCF
TOI
$2.2M
$-1.8M
MRCY
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-2.6%
MRCY

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MRCY
MRCY
TOI
TOI
Revenue
$235.8M
$142.0M
Net Profit
$-2.9M
$-7.5M
Gross Margin
99.6%
Operating Margin
72.9%
-4.9%
Net Margin
-1.2%
-5.3%
Revenue YoY
11.5%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.04
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRCY
MRCY
TOI
TOI
Q1 26
$235.8M
Q4 25
$232.9M
$142.0M
Q3 25
$225.2M
$136.6M
Q2 25
$273.1M
$119.8M
Q1 25
$211.4M
$104.4M
Q4 24
$223.1M
$100.3M
Q3 24
$204.4M
$99.9M
Q2 24
$248.6M
$98.6M
Net Profit
MRCY
MRCY
TOI
TOI
Q1 26
$-2.9M
Q4 25
$-15.1M
$-7.5M
Q3 25
$-12.5M
$-16.5M
Q2 25
$16.4M
$-17.0M
Q1 25
$-19.2M
$-19.6M
Q4 24
$-17.6M
$-13.2M
Q3 24
$-17.5M
$-16.1M
Q2 24
$-10.8M
$-15.5M
Gross Margin
MRCY
MRCY
TOI
TOI
Q1 26
99.6%
Q4 25
26.0%
Q3 25
27.9%
Q2 25
31.0%
Q1 25
27.0%
Q4 24
27.3%
Q3 24
25.3%
Q2 24
29.5%
Operating Margin
MRCY
MRCY
TOI
TOI
Q1 26
72.9%
Q4 25
-4.6%
-4.9%
Q3 25
-3.8%
-5.9%
Q2 25
8.6%
-9.4%
Q1 25
-8.2%
-9.5%
Q4 24
-5.6%
-11.9%
Q3 24
-6.6%
-13.9%
Q2 24
-3.2%
-16.6%
Net Margin
MRCY
MRCY
TOI
TOI
Q1 26
-1.2%
Q4 25
-6.5%
-5.3%
Q3 25
-5.6%
-12.1%
Q2 25
6.0%
-14.2%
Q1 25
-9.1%
-18.8%
Q4 24
-7.9%
-13.1%
Q3 24
-8.6%
-16.1%
Q2 24
-4.3%
-15.7%
EPS (diluted)
MRCY
MRCY
TOI
TOI
Q1 26
$-0.04
Q4 25
$-0.26
$-0.04
Q3 25
$-0.21
$-0.14
Q2 25
$0.28
$-0.15
Q1 25
$-0.33
$-0.21
Q4 24
$-0.30
$-0.14
Q3 24
$-0.30
$-0.18
Q2 24
$-0.18
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRCY
MRCY
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$331.8M
Total DebtLower is stronger
$591.5M
Stockholders' EquityBook value
$1.5B
$-15.7M
Total Assets
$2.5B
$164.7M
Debt / EquityLower = less leverage
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRCY
MRCY
TOI
TOI
Q1 26
$331.8M
Q4 25
$335.0M
Q3 25
$304.7M
Q2 25
$309.1M
Q1 25
$269.8M
Q4 24
$242.6M
Q3 24
$158.1M
Q2 24
$180.5M
$9.9M
Total Debt
MRCY
MRCY
TOI
TOI
Q1 26
$591.5M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MRCY
MRCY
TOI
TOI
Q1 26
$1.5B
Q4 25
$1.5B
$-15.7M
Q3 25
$1.5B
$-12.3M
Q2 25
$1.5B
$-9.0M
Q1 25
$1.5B
$5.1M
Q4 24
$1.5B
$3.6M
Q3 24
$1.5B
$15.5M
Q2 24
$1.5B
$29.2M
Total Assets
MRCY
MRCY
TOI
TOI
Q1 26
$2.5B
Q4 25
$2.5B
$164.7M
Q3 25
$2.5B
$163.6M
Q2 25
$2.4B
$159.8M
Q1 25
$2.4B
$164.0M
Q4 24
$2.4B
$172.7M
Q3 24
$2.4B
$179.2M
Q2 24
$2.4B
$179.6M
Debt / Equity
MRCY
MRCY
TOI
TOI
Q1 26
0.40×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRCY
MRCY
TOI
TOI
Operating Cash FlowLast quarter
$6.4M
$3.2M
Free Cash FlowOCF − Capex
$-1.8M
$2.2M
FCF MarginFCF / Revenue
-0.8%
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$73.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRCY
MRCY
TOI
TOI
Q1 26
$6.4M
Q4 25
$51.6M
$3.2M
Q3 25
$2.2M
$-12.6M
Q2 25
$38.1M
$-10.2M
Q1 25
$30.0M
$-5.0M
Q4 24
$85.5M
$4.2M
Q3 24
$-14.7M
$819.0K
Q2 24
$71.8M
$-15.7M
Free Cash Flow
MRCY
MRCY
TOI
TOI
Q1 26
$-1.8M
Q4 25
$45.7M
$2.2M
Q3 25
$-4.4M
$-13.2M
Q2 25
$34.0M
$-11.4M
Q1 25
$24.1M
$-5.3M
Q4 24
$81.9M
$2.4M
Q3 24
$-20.9M
$417.0K
Q2 24
$61.4M
$-17.5M
FCF Margin
MRCY
MRCY
TOI
TOI
Q1 26
-0.8%
Q4 25
19.6%
1.5%
Q3 25
-1.9%
-9.7%
Q2 25
12.4%
-9.5%
Q1 25
11.4%
-5.1%
Q4 24
36.7%
2.4%
Q3 24
-10.2%
0.4%
Q2 24
24.7%
-17.7%
Capex Intensity
MRCY
MRCY
TOI
TOI
Q1 26
Q4 25
2.5%
0.7%
Q3 25
2.9%
0.4%
Q2 25
1.5%
1.0%
Q1 25
2.8%
0.3%
Q4 24
1.6%
1.8%
Q3 24
3.1%
0.4%
Q2 24
4.2%
1.9%
Cash Conversion
MRCY
MRCY
TOI
TOI
Q1 26
Q4 25
Q3 25
Q2 25
2.33×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRCY
MRCY

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons